Lucas Elijovich, MD
Neurology · Memphis, TNNPI 1750480554
Payments from drug & device makers
Across 543 payments — averaging $1321.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Microvention, Inc.$280K
- MIVI Neuroscience, Inc.$110K
- Medtronic$100K
- Medical Device Business Services, Inc.$86K
- Stryker$42K
- Siemens Medical Solutions USA, Inc.$38K
- plus $62K from 15 others
Across 3 payments — averaging $1445.83 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Microvention, Inc.$2K
- Novartis$1K
- Balt USA, LLC$1K
What the payments were for
- Consulting fees$174,77242%
- Speaking & faculty fees$178,22543%
- Travel & lodging$53,27913%
- Food & beverage$9,0612%
- Gifts$110%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Microvention, Inc. | 245 | $280,127 |
| MIVI Neuroscience, Inc. | 24 | $109,510 |
| Medtronic(3 entities) | 38 | $100,095 |
| Medical Device Business Services, Inc. | 90 | $86,055 |
| Stryker | 13 | $42,246 |
| Siemens Medical Solutions USA, Inc. | 50 | $37,817 |
| Balt USA, LLC | 33 | $30,249 |
| Viz.ai, Inc. | 2 | $19,500 |
| Penumbra, Inc. | 11 | $5,925 |
| Scientia Vascular | 4 | $3,868 |
| Johnson & Johnson | 8 | $596 |
| Inari Medical, Inc. | 1 | $500 |
| Rapid Medical Ltd | 6 | $370 |
| Imperative Care, Inc | 9 | $363 |
| Silk Road Medical, Inc. | 1 | $189 |
| Route 92 Medical, Inc. | 1 | $107 |
| Qapel Medical Inc | 2 | $48 |
| AbbVie | 2 | $38 |
| Boston Scientific | 1 | $18 |
| Chiesi USA, Inc. | 1 | $17 |
| AstraZeneca | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WEB$139,105
- WEB Aneurysm Embolization System$78,703
- TRUFILL$53,695
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$38,505
- EMBOGUARD$31,063
- CorPath Imaging System$17,397
- PULSERIDER$12,707
- Magic Infusion Catheter$8,784
- Embotrap$7,919
- CEREPAK UNIFORM$7,908
- Aristotle Guidewire$1,950
- MAGIC Catheter$1,600
- Optima Thermal Coil System$1,600
- ARTIS icono biplane$1,049
- Artis icono$583
- CT THROMBECTOMY SYSTEM KIT$500
- FLOWTRIEVER CATHETER, S$500
- ENROUTE Transcarotid Neuroprotection System$377
- Penumbra System$260
- STENT$239
How this compares
$717,650 in reported general payments places this provider in the 90th percentile of 361 neurology providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 41 | $28,487 |
| BrilintaTicagrelor | 30 | $13,081 |
| Levetiracetam | 37 | $1,992 |
| ClopidogrelClopidogrel Bisulfate | 54 | $478 |
| Atorvastatin Calcium | 13 | $150 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaBrilinta | $14 | $13,08130 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 361 neurology providers in Tennessee.
Other neurology in Memphis
- Lora McGillMemphis$7.5M
- Anthony NicholasMemphis$1.8M
- Mark LedouxMemphis$1.2M
- Tulio BertoriniMemphis$1M
- Rekha PillaiMemphis$355K
- Khalid AlsherbiniMemphis$249K
- Andrei AlexandrovMemphis$237K
- Ghaida ZaidMemphis$230K
- Nitin GoyalMemphis$223K
- Rozita KhaliliMemphis$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.